Challenges and Limitations in ADSC Therapies
Despite its promise, the adipose-derived stem cell market faces several challenges. Regulatory compliance, ethical considerations, and high costs of treatment are major barriers to widespread adoption. Clinical outcomes can vary depending on the source, isolation methods, and handling of stem cells, which underscores the need for standardized protocols.
The development of reliable, scalable, and cost-effective ADSC therapies is essential for sustaining the projected growth of the Adipose-derived Stem Cell Market Size. Companies must invest in quality control, training, and regulatory compliance to maintain credibility and public trust. Addressing these challenges will ensure long-term growth and wider adoption of ADSC-based therapies.